Biocure Technology, Inc. (CURE.X.CX)
0.04
0.00 (0.00%)
CAD |
CNSX |
Aug 27, 16:00
Biocure Technology Debt to Equity Ratio : 0.0372 for Dec. 31, 2025
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2025 | 0.0372 |
| September 30, 2025 | 0.0351 |
| June 30, 2025 | 0.0381 |
| March 31, 2025 | 0.0387 |
| December 31, 2024 | 0.037 |
| September 30, 2024 | 0.0306 |
| June 30, 2024 | 0.0292 |
| March 31, 2024 | 0.0277 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | -1.768 |
| June 30, 2022 | -2.173 |
| March 31, 2022 | -2.852 |
| Date | Value |
|---|---|
| December 31, 2021 | -6.951 |
| September 30, 2021 | -1.237 |
| June 30, 2021 | -1.196 |
| March 31, 2021 | -1.766 |
| December 31, 2020 | -1.968 |
| September 30, 2020 | -5.009 |
| June 30, 2020 | -16.29 |
| March 31, 2020 | -38.31 |
| December 31, 2019 | -12.32 |
| September 30, 2019 | 2.216 |
| June 30, 2019 | 1.987 |
| March 31, 2019 | 1.109 |
| December 31, 2018 | |
| September 30, 2018 | 0.3693 |
| June 30, 2018 | 0.3691 |
| March 31, 2018 | 0.1913 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.011M |
| Total Liabilities (Quarterly) | 0.435M |
| Shareholders Equity (Quarterly) | 1.576M |
| Current Ratio | 0.1046 |
| Net Debt Paydown Yield | -0.15% |